Skip to main content

Lansoprazole Recalled

October 05, 2016

The US Food and Drug Administration (FDA) reported the recall of one lot of lansoprazole delayed-release capsules, USP, 30 mg (NDC 63739-0555-10).

What prompted the Class III recall? The inner packaging incorrectly indicated that the medication was omeprazole.

The impacted lot is #0111295, with an expiration of September 2017.


Massive Recall of Blood Thinners, Antibiotic
Sandoz Recalls Hypotension Med, Vasoconstrictor


The products were manufactured by Dr. Reddy’s Laboratories for Mckesson Packaging Services.

 Mckesson Packaging Services just launched a recall of alprazolam because the blister cards did not contain any product information.

In April, Dr. Reddy’s Laboratories launched a recall of zoledronic acid injection due to defective seals.


--Stephanie Vaccaro



US Food and Drug Administration. FDA Enforcement Report – Week of October 5, 2016. Accessed October 6, 2016.




Back to Top